semaglutide inventor Inside the discovery of Interview with Weight Loss Drugs

JAMA Psychiatry 82 (1)

Among the elements that could help new growth potential are new delivery formats (pills), fierce competition between drug makers and a broader insurance coverage (notably if public and private health systems see GLP-1 as a tool to prevent severe and costly conditions)

NOVO NORDISK EXECUTIVE REPORTS HIGH INTEREST FOR ONCE-DAILY, ORAL WEIGHT-LOSS PILL "Our actions today answer that call and remove cost barriers so the value of Wegovy and Ozempic can be realized by more patients," he explained

Trusted by GLP-1 patients across the UK Freya C

One of the most significant of these is the activation of SIRT1, often called a longevity gene. SIRT1 helps manage insulin sensitivity and supports healthier blood sugar regulation, which is fundamental for sustained energy and preventing the metabolic strain that can lead to weight gain